Insider Selling: Astera Labs (NASDAQ:ALAB) General Counsel Sells 796 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the transaction, the general counsel owned 103,343 shares in the company, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Philip Mazzara also recently made the following trade(s):

• On Monday, May 18th, Philip Mazzara sold 14,076 shares of Astera Labs stock. The shares were sold at an average price of $231.78, for a total value of $3,262,535.28.
• On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00.
• On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.

Astera Labs Stock Up 3.9%

NASDAQ:ALAB traded up $11.84 on Tuesday, reaching $318.72. 8,097,769 shares of the company’s stock traded hands, compared to its average volume of 5,548,043. The stock has a 50-day simple moving average of $174.13 and a 200-day simple moving average of $160.46. The firm has a market cap of $54.63 billion, a PE ratio of 215.35, a P/E/G ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $321.99.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period last year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Nordea Investment Management AB bought a new stake in Astera Labs during the fourth quarter worth approximately $2,028,000. Geneva Partners LLC bought a new stake in Astera Labs during the third quarter worth approximately $1,876,000. Numerai GP LLC increased its stake in Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB increased its stake in Astera Labs by 289.5% during the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares during the last quarter. Finally, Paragon Advisors LLC bought a new stake in Astera Labs during the third quarter worth approximately $1,829,000. Institutional investors own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. UBS Group assumed coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday. Roth Mkm reaffirmed a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Barclays lifted their target price on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.